Related Experiment Video
Updated: May 18, 2026

Following Cell-fate in E. coli After Infection by Phage Lambda
Published on: October 14, 2011
Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent
Mathias Schmelcher1, Olga Korobova, Nina Schischkova
1ANRI, Agricultural Research Service, US Department of Agriculture, 10300 Baltimore Avenue, Building 230, BARC-EAST, Beltsville, MD 20705, USA.
Abstract:
Staphylococcus aureus is an important pathogen, with methicillin-resistant (MRSA) and multi-drug resistant strains becoming increasingly prevalent in both human and veterinary clinics. S. aureus causing bovine mastitis yields high annual losses to the dairy industry. Conventional treatment of mastitis by broad range antibiotics is often not successful and may contribute to development of antibiotic resistance. Bacteriophage endolysins present a promising new source of antimicrobials. The endolysin of prophage ΦSH2 of Staphylococcus haemolyticus strain JCSC1435 (ΦSH2 lysin) is a peptidoglycan hydrolase consisting of two catalytic domains (CHAP and amidase) and an SH3b cell wall binding domain. In this work, we demonstrated its lytic activity against live staphylococcal cells and investigated the contribution of each functional module to bacterial lysis by testing a series of deletion constructs in zymograms and turbidity reduction assays. The CHAP domain exhibited three-fold higher activity than the full length protein and optimum activity in physiological saline. This activity was further enhanced by the presence of bivalent calcium ions. The SH3b domain was shown to be required for full activity of the complete ΦSH2 lysin. The full length enzyme and the CHAP domain showed activity against multiple staphylococcal strains, including MRSA strains, mastitis isolates, and CoNS.
Insights
Bacteriophage endolysins offer a novel antimicrobial approach against resistant Staphylococcus aureus. The ΦSH2 lysin, particularly its CHAP domain, shows significant lytic activity against MRSA and mastitis-causing strains.
Area of Science:
- Microbiology
- Biochemistry
- Antimicrobial Research
Background:
- Staphylococcus aureus, including methicillin-resistant (MRSA) strains, poses a significant threat in human and veterinary medicine.
- Antibiotic resistance in S. aureus necessitates the development of alternative therapeutic strategies.
- Bovine mastitis caused by S. aureus results in substantial economic losses for the dairy industry.
Purpose of the Study:
- To characterize the lytic activity of Staphylococcus haemolyticus prophage ΦSH2 endolysin (ΦSH2 lysin).
- To investigate the functional contribution of its catalytic (CHAP, amidase) and cell wall binding (SH3b) domains to bacterial lysis.
- To evaluate the efficacy of ΦSH2 lysin against clinically relevant staphylococcal strains.
Main Methods:
- Deletion constructs of ΦSH2 lysin were created to analyze domain contributions.
- Zymogram assays and turbidity reduction assays were employed to assess lytic activity.
- Activity was tested under various conditions, including different salt concentrations and in the presence of divalent ions.
Main Results:
- The CHAP domain alone demonstrated three-fold higher lytic activity than the full-length ΦSH2 lysin.
- Optimal activity for the CHAP domain was observed in physiological saline, further enhanced by calcium ions.
- The SH3b domain was essential for the full lytic activity of the complete ΦSH2 lysin.
- Both the full-length enzyme and the CHAP domain exhibited potent activity against diverse staphylococcal strains, including MRSA, mastitis isolates, and coagulase-negative staphylococci (CoNS).
Conclusions:
- The CHAP domain is a potent lytic enzyme effective against various staphylococci.
- ΦSH2 lysin represents a promising antimicrobial agent for combating resistant staphylococcal infections, including bovine mastitis.
- Understanding domain contributions aids in the engineering of more effective phage-derived antimicrobials.
More Related Videos
Related Concept Videos
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
Viral Replication: Lytic Cycle
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Lysosomal Hydrolases

